Recent events
Recent events tied to this brand in public sources.
Back to profile16 entries
2026
BD introduces UltraCor Twirl breast tissue markers in India
BD introduced UltraCor Twirl Breast Tissue Markers in India; the article says the markers are now available across India.
2022
BD reports first-quarter fiscal 2022 results
BD announced results for its first quarter of fiscal 2022, which ended December 31, 2021. Revenue was $5.0 billion, down 6.0% as reported, and adjusted diluted EPS was $3.64.
2022
BD raises fiscal 2022 revenue and EPS guidance
BD raised its full-year fiscal 2022 revenue and adjusted diluted EPS guidance. It now expects revenue of $19.55 billion to $19.75 billion and adjusted diluted EPS of $12.80 to $13.00.
2021
BD completes acquisition of Scanwell Health
BD announced that it had completed its acquisition of Scanwell Health, a privately held company specializing in smartphone-enabled at-home medical tests. BD said Scanwell would serve as a digital platform for planned at-home diagnostic tests.
2021
BD launches SCF PremiumCoat plunger stopper
BD launched the SCF PremiumCoat plunger stopper in partnership with Aptar Pharma. The syringe component is designed to support injection of biologics using a 1 mL pre-filled syringe.
2021
BD selected for Washington state's school testing program
BD announced it had been selected by Washington state as a digitally read rapid antigen test option for COVID-19 testing and screening in K-12 schools. Schools can use the BD Veritor Plus system through a partnership with the Washington Department of Health and The Health Commons Project's Learn to Return program.
2021
BD launches COR PX/GX molecular diagnostic system in the United States
BD announced the U.S. launch of the BD COR PX/GX System, a fully automated high-throughput diagnostic system for infectious-disease molecular testing in centralized laboratories.
2021
BD acquires Tepha
BD announced that it had acquired Tepha, a developer and manufacturer of resorbable polymer technology. The acquired portfolio includes Tepha's GalaFLEX products.
2021
BD partners with USATF to provide rapid COVID-19 testing
BD and USA Track & Field partnered to provide rapid COVID-19 testing for USATF athletes at Journey to Gold meets using the BD Veritor Plus system.
2021
BD and ImageMover agree to offer COVID-19 test reporting app
BD announced an agreement with ImageMover to offer a companion mobile app for reporting SARS-CoV-2 antigen test results from the BD Veritor Plus System at everyday testing locations. The app was available immediately to BD Veritor Plus System customers.
2021
BD acquires GSL Solutions
BD announced that it had acquired GSL Solutions, a developer of smart medication devices, expanding BD’s medication management capabilities for retail and outpatient pharmacies. The transaction terms were not disclosed.
2020
BD acquires CUBEX medical business assets
BD announced that it had acquired the Medical Business assets of CUBEX LLC, expanding its medication management offerings into the care continuum space.
2020
BD recalls sterile disposable injection needles in South Korea
Becton Dickinson Medical (S) Pte. Ltd. voluntarily recalled specified batches of sterile disposable injection needles after a customer complaint from South Korea reported that some packaging may have been opened and incorrectly cut. The article says the affected batch was not imported into China and the recall did not affect the Chinese market.
2020
BD completes acquisition of Straub Medical
BD completed its acquisition of privately held Straub Medical AG, which develops and sells atherectomy and thrombectomy devices.
2020
BD and BARDA announce manufacturing partnership for injection devices
BD announced a strategic public-private partnership with BARDA to develop new manufacturing lines for injection devices and provide the U.S. government priority access to devices for current and future pandemic vaccination efforts.
2020
BD announces launch of rapid COVID-19 antigen test
BD announced the launch of a portable point-of-care SARS-CoV-2 diagnostic test for use with the BD Veritor Plus System; the test delivers results in 15 minutes.